MoneyWorks4Me

Gland Pharma - Quaterly Results

22 Oct 2021 Evaluate
The sales surged to Rs. 10804.69 millions, up 29.94% for the September 2021 quarter as against Rs. 8315.00 millions during the corresponding quarter previous year.A good growth in profit of 38.04% reported to Rs. 3021.20  millions over Rs. 2188.57 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 4278.38 millions from 3180.52 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 10804.69 8315.00 29.94 22343.69 17157.09 30.23 34628.76 26332.40 31.51
Other Income 511.97 203.52 151.56 1130.37 524.32 115.59 1347.76 1391.68 -3.16
PBIDT 4278.38 3180.52 34.52 9259.79 7627.53 21.40 14370.43 10946.35 31.28
Interest 10.24 7.60 34.74 20.25 12.31 64.50 34.11 71.82 -52.51
PBDT 4268.14 3172.92 34.52 9239.54 7615.22 21.33 14336.32 10874.53 31.83
Depreciation 261.10 246.63 5.87 513.87 488.93 5.10 987.80 945.87 4.43
PBT 4007.04 2926.29 36.93 8725.67 7126.29 22.44 13348.52 9928.66 34.44
TAX 985.84 737.72 33.63 2197.72 1801.82 21.97 3378.47 2200.08 53.56
Deferred Tax 56.89 -6.16 -1023.54 41.83 -10.68 -491.67 1.20 -318.21 -100.38
PAT 3021.20 2188.57 38.04 6527.95 5324.47 22.60 9970.05 7728.58 29.00
Equity 164.23 154.95 5.99 164.23 154.95 5.99 163.59 154.95 5.58
PBIDTM(%) 39.60 38.25 3.52 41.44 44.46 -6.78 41.50 41.57 -0.17
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..